DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:CPR - NL0015435975 - Common Stock
5.528 EUR
+0.16 (+3.06%)
We assign a fundamental rating of 4 out of 10 to CPR. CPR was compared to 24 industry peers in the Beverages industry. Both the profitability and the financial health of CPR get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, CPR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
CPR had positive earnings in the past year.
CPR had a positive operating cash flow in the past year.
In the past 5 years CPR has always been profitable.
In the past 5 years CPR always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 2.51%, CPR is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
CPR has a worse Return On Equity (5.44%) than 70.83% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.03%, CPR is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CPR is in line with the industry average of 7.78%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.51% | ||
| ROE | 5.44% | ||
| ROIC | 7.03% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
1.3 Margins
CPR has a Profit Margin of 6.57%. This is comparable to the rest of the industry: CPR outperforms 41.67% of its industry peers.
CPR's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 21.32%, CPR is doing good in the industry, outperforming 62.50% of the companies in the same industry.
In the last couple of years the Operating Margin of CPR has remained more or less at the same level.
The Gross Margin of CPR (57.55%) is better than 75.00% of its industry peers.
CPR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% |
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPR is creating some value.
Compared to 1 year ago, CPR has more shares outstanding
CPR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CPR has remained at the same level compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.49 indicates that CPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
CPR has a Altman-Z score of 2.49. This is in the better half of the industry: CPR outperforms 70.83% of its industry peers.
The Debt to FCF ratio of CPR is 8.49, which is on the high side as it means it would take CPR, 8.49 years of fcf income to pay off all of its debts.
CPR has a Debt to FCF ratio (8.49) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.64 indicates that CPR is somewhat dependend on debt financing.
CPR has a better Debt to Equity ratio (0.64) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 8.49 | ||
| Altman-Z | 2.49 |
ROIC/WACC1.05
WACC6.69%
2.3 Liquidity
CPR has a Current Ratio of 2.32. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.32, CPR belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
CPR has a Quick Ratio of 2.32. This is a bad value and indicates that CPR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.91, CPR is in the better half of the industry, outperforming 79.17% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
The earnings per share for CPR have decreased strongly by -40.50% in the last year.
Measured over the past years, CPR shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.12% on average per year.
The Revenue has been growing slightly by 5.18% in the past year.
CPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.75% yearly.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
3.2 Future
CPR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.73% yearly.
CPR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.72% yearly.
EPS Next Y0.81%
EPS Next 2Y4.38%
EPS Next 3Y6.89%
EPS Next 5Y11.73%
Revenue Next Year1.7%
Revenue Next 2Y2.14%
Revenue Next 3Y3.2%
Revenue Next 5Y4.72%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 32.52 indicates a quite expensive valuation of CPR.
Compared to the rest of the industry, the Price/Earnings ratio of CPR indicates a slightly more expensive valuation: CPR is more expensive than 79.17% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 25.45. CPR is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 17.09, CPR is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as CPR.
When comparing the Price/Forward Earnings ratio of CPR to the average of the S&P500 Index (34.46), we can say CPR is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.52 | ||
| Fwd PE | 17.09 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CPR.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CPR is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.21 | ||
| EV/EBITDA | 11.06 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)40.16
PEG (5Y)N/A
EPS Next 2Y4.38%
EPS Next 3Y6.89%
5. Dividend
5.1 Amount
CPR has a Yearly Dividend Yield of 1.12%. Purely for dividend investing, there may be better candidates out there.
CPR's Dividend Yield is slightly below the industry average, which is at 3.16.
Compared to an average S&P500 Dividend Yield of 2.45, CPR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.12% |
5.2 History
The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
38.69% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP38.69%
EPS Next 2Y4.38%
EPS Next 3Y6.89%
BIT:CPR (11/21/2025, 7:00:00 PM)
5.528
+0.16 (+3.06%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners22.94%
Inst Owner ChangeN/A
Ins Owners51.06%
Ins Owner ChangeN/A
Market Cap6.81B
Revenue(TTM)3.07B
Net Income(TTM)201.60M
Analysts71.54
Price Target6.88 (24.46%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.12% |
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.62%
PT rev (3m)-2.06%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.57%
EPS NY rev (3m)-0.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.61%
Revenue NY rev (3m)-1.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.52 | ||
| Fwd PE | 17.09 | ||
| P/S | 2.22 | ||
| P/FCF | 21.21 | ||
| P/OCF | 10.44 | ||
| P/B | 1.84 | ||
| P/tB | 56.07 | ||
| EV/EBITDA | 11.06 |
EPS(TTM)0.17
EY3.08%
EPS(NY)0.32
Fwd EY5.85%
FCF(TTM)0.26
FCFY4.71%
OCF(TTM)0.53
OCFY9.58%
SpS2.49
BVpS3.01
TBVpS0.1
PEG (NY)40.16
PEG (5Y)N/A
Graham Number3.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.51% | ||
| ROE | 5.44% | ||
| ROCE | 9.58% | ||
| ROIC | 7.03% | ||
| ROICexc | 7.57% | ||
| ROICexgc | 17.42% | ||
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% | ||
| FCFM | 10.45% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexgc growth 3Y-20.45%
ROICexgc growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score6
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 8.49 | ||
| Debt/EBITDA | 2.97 | ||
| Cap/Depr | 230.39% | ||
| Cap/Sales | 10.79% | ||
| Interest Coverage | 6.41 | ||
| Cash Conversion | 81.69% | ||
| Profit Quality | 159.18% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.49 |
F-Score6
WACC6.69%
ROIC/WACC1.05
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
EPS Next Y0.81%
EPS Next 2Y4.38%
EPS Next 3Y6.89%
EPS Next 5Y11.73%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
Revenue Next Year1.7%
Revenue Next 2Y2.14%
Revenue Next 3Y3.2%
Revenue Next 5Y4.72%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year24.36%
EBIT Next 3Y12.31%
EBIT Next 5Y10.3%
FCF growth 1Y290.11%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y205.34%
OCF growth 3Y11.5%
OCF growth 5Y13.06%
DAVIDE CAMPARI-MILANO NV / CPR.MI FAQ
Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?
ChartMill assigns a fundamental rating of 4 / 10 to CPR.MI.
What is the valuation status of DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?
ChartMill assigns a valuation rating of 2 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.
What is the profitability of CPR stock?
DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 5 / 10.
What is the valuation of DAVIDE CAMPARI-MILANO NV based on its PE and PB ratios?
The Price/Earnings (PE) ratio for DAVIDE CAMPARI-MILANO NV (CPR.MI) is 32.52 and the Price/Book (PB) ratio is 1.84.
How sustainable is the dividend of DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?
The dividend rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 2 / 10 and the dividend payout ratio is 38.69%.